High-dose palliative radiotherapy in metastatic castrate resistant prostate cancer – is it worthwhile? A single-centre outcome. (September 2022) - Jackson, Malcolm; Hannaway, Nicola; Burns, Alexander; Pearson, Rachel; Frew, John; Chandler, Rob; Pedley, Ian; Jiang, Xue